Glycohale FB Inhaler 120 MDI

Glycohale FB Inhaler 120 MDI is used in the treatment of patients with chronic obstructive pulmonary disease to relieve symptoms and prevent exacerbations. COPD is a group of lung diseases that includes emphysema (shortness of breath) and chronic bronchitis (inflammation of the lining of the bronchial tubes).

Glycohale FB Inhaler 120 MDI contains Budesonide, glycopyrrolate, and formoterol fumarate dihydrate. Formoterol fumarate works by relaxing muscles and widening the lungs' airways. Glycopyrrolate reduces secretions in the airways. Budesonide acts on nasal lining cells and prevents the release of inflammatory mediators.

Glycohale FB Inhaler 120 MDI may cause specific side effects, including oral thrush, cough, difficulty breathing, chills, back pain, muscle spasms, low blood pressure, nausea, and vomiting. Inform your doctor if these side effects persist or worsen.

Inform your doctor if you are allergic to Glycohale FB Inhaler 120 MDI. Before taking Glycohale FB Inhaler 120 MDI, let your doctor know if you have any history of liver/kidney disease, glaucoma, asthma, heart disease, paradoxical bronchospasm, hypokalemia, or hyperglycaemia. If you are pregnant or breastfeeding, please inform your doctor before using Glycohale FB Inhaler 120 MDI. 

Glycohale FB Inhaler 120 MDI is used in the long-term treatment of chronic obstructive pulmonary disease (COPD). The detailed uses of Glycohale FB Inhaler 120 MDI are as follows:

• Reduces lung inflammation: Glycohale FB Inhaler 120 MDI helps decrease airway swelling and inflammation, improving breathing.
• Relaxes airway muscles: Glycohale FB Inhaler 120 MDI helps widen the airways for easier airflow and provides up to 12 hours of sustained bronchodilation.
• Prevents bronchoconstriction: Glycopyrrolate in Glycohale FB Inhaler 120 MDI blocks signals that cause airway tightening, reducing COPD symptoms.

• Follow your doctor's instructions on the dosage and timing of this medication to ensure safety.
• Place the mouthpiece between your lips, press the inhaler, and breathe in slowly. Hold your breath for a few seconds, then slowly breathe out.
• Always shake the container for 5 seconds before each use.
• Rinse your mouth with water and spit it out after using it to help prevent fungal infections in your mouth and throat.

• Glycohale FB Inhaler 120 MDI is a combination inhalation therapy that contains budesonide (an inhaled corticosteroid), glycopyrronium, and formoterol (a long-acting beta-2 adrenergic agonist).
• This combination offers both anti-inflammatory and bronchodilator actions, providing comprehensive control over respiratory conditions such as Asthma and Chronic Obstructive Pulmonary Disease (COPD).
• Glycohale FB Inhaler 120 MDI is used as a regular maintenance therapy for individuals with asthma where the use of inhaled corticosteroids and long-acting beta-agonists (LABA) is appropriate.
• It reduces airway inflammation and prevents bronchospasm, thereby minimising the frequency and severity of asthma attacks.
• Helps maintain long-term asthma control, improves lung function, and enhances quality of life.
• Glycohale FB Inhaler 120 MDI is also indicated for the regular treatment of moderate to severe COPD in patients who experience frequent symptoms and have a history of exacerbation.
• Glycohale FB Inhaler 120 MDI decreases the rate and severity of COPD exacerbations and maintains day-to-day function.

• Discontinue the medicine and inform your doctor if you observe any allergic reactions or are known allergic to any ingredients.
• This medicine is contraindicated for use in asthma patients, acute episodes of COPD, and use of other LABA drugs, as it can cause serious side effects.
• Glycohale FB Inhaler 120 MDI may cause glaucoma, oropharyngeal candidiasis, adrenal suppression, cardiovascular effects, paradoxical bronchospasm, serious anaphylactic reactions, hypokalaemia, hyperglycaemia, pneumonia and deterioration of disease.
• Inform your doctor if you have any conditions like liver/kidney disease, glaucoma, asthma, heart disease, seizures, weak immune system, osteoporosis, diabetes, thyroid disorders, prostate/bladder problems, a serious infection, or medication history of anticholinergics, atropine, other LABA drugs, antifungal or anti-HIV medicines if you are pregnant or breastfeeding, please inform your doctor before using Glycohale FB Inhaler 120 MDI.
• Glycohale FB Inhaler 120 MDI is not recommended for children as the safety is not established.
• This medicine may cause harm to the developing baby. Hence, it is advised to inform your doctor if you are pregnant or breastfeeding before starting the treatment.